<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-05-10" modified="2017-12-20" version="145">
<accession>Q7Z2W4</accession>
<accession>A4D1R2</accession>
<accession>A4D1S4</accession>
<accession>Q8IW57</accession>
<accession>Q8TAJ3</accession>
<accession>Q96N79</accession>
<accession>Q9H8R9</accession>
<accession>Q9P0Y7</accession>
<name>ZCCHV_HUMAN</name>
<protein>
<recommendedName>
<fullName>Zinc finger CCCH-type antiviral protein 1</fullName>
</recommendedName>
<alternativeName>
<fullName>ADP-ribosyltransferase diphtheria toxin-like 13</fullName>
<shortName>ARTD13</shortName>
</alternativeName>
<alternativeName>
<fullName>Zinc finger CCCH domain-containing protein 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Zinc finger antiviral protein</fullName>
<shortName>ZAP</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">ZC3HAV1</name>
<name type="synonym">ZC3HDC2</name>
<name type="ORF">PRO1677</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="1999-03" db="EMBL/GenBank/DDBJ databases">
<title>Functional prediction of the coding sequences of 5 new genes deduced by analysis of cDNA clones from human fetal liver.</title>
<authorList>
<person name="Zhang C."/>
<person name="Yu Y."/>
<person name="Zhang S."/>
<person name="Zhou G."/>
<person name="Wei H."/>
<person name="Bi J."/>
<person name="Xu W."/>
<person name="Zai Y."/>
<person name="Feng F."/>
<person name="Liu M."/>
<person name="He F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5)</scope>
<scope>VARIANT GLN-565</scope>
<source>
<tissue>Fetal liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4)</scope>
<scope>VARIANTS LYS-485; GLN-565 AND GLU-701</scope>
<source>
<tissue>Kidney</tissue>
<tissue>Ovarian carcinoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS GLU-701 AND ILE-851</scope>
<source>
<tissue>Endometrium</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Science" volume="300" first="767" last="772">
<title>Human chromosome 7: DNA sequence and biology.</title>
<authorList>
<person name="Scherer S.W."/>
<person name="Cheung J."/>
<person name="MacDonald J.R."/>
<person name="Osborne L.R."/>
<person name="Nakabayashi K."/>
<person name="Herbrick J.-A."/>
<person name="Carson A.R."/>
<person name="Parker-Katiraee L."/>
<person name="Skaug J."/>
<person name="Khaja R."/>
<person name="Zhang J."/>
<person name="Hudek A.K."/>
<person name="Li M."/>
<person name="Haddad M."/>
<person name="Duggan G.E."/>
<person name="Fernandez B.A."/>
<person name="Kanematsu E."/>
<person name="Gentles S."/>
<person name="Christopoulos C.C."/>
<person name="Choufani S."/>
<person name="Kwasnicka D."/>
<person name="Zheng X.H."/>
<person name="Lai Z."/>
<person name="Nusskern D.R."/>
<person name="Zhang Q."/>
<person name="Gu Z."/>
<person name="Lu F."/>
<person name="Zeesman S."/>
<person name="Nowaczyk M.J."/>
<person name="Teshima I."/>
<person name="Chitayat D."/>
<person name="Shuman C."/>
<person name="Weksberg R."/>
<person name="Zackai E.H."/>
<person name="Grebe T.A."/>
<person name="Cox S.R."/>
<person name="Kirkpatrick S.J."/>
<person name="Rahman N."/>
<person name="Friedman J.M."/>
<person name="Heng H.H.Q."/>
<person name="Pelicci P.G."/>
<person name="Lo-Coco F."/>
<person name="Belloni E."/>
<person name="Shaffer L.G."/>
<person name="Pober B."/>
<person name="Morton C.C."/>
<person name="Gusella J.F."/>
<person name="Bruns G.A.P."/>
<person name="Korf B.R."/>
<person name="Quade B.J."/>
<person name="Ligon A.H."/>
<person name="Ferguson H."/>
<person name="Higgins A.W."/>
<person name="Leach N.T."/>
<person name="Herrick S.R."/>
<person name="Lemyre E."/>
<person name="Farra C.G."/>
<person name="Kim H.-G."/>
<person name="Summers A.M."/>
<person name="Gripp K.W."/>
<person name="Roberts W."/>
<person name="Szatmari P."/>
<person name="Winsor E.J.T."/>
<person name="Grzeschik K.-H."/>
<person name="Teebi A."/>
<person name="Minassian B.A."/>
<person name="Kere J."/>
<person name="Armengol L."/>
<person name="Pujana M.A."/>
<person name="Estivill X."/>
<person name="Wilson M.D."/>
<person name="Koop B.F."/>
<person name="Tosi S."/>
<person name="Moore G.E."/>
<person name="Boright A.P."/>
<person name="Zlotorynski E."/>
<person name="Kerem B."/>
<person name="Kroisel P.M."/>
<person name="Petek E."/>
<person name="Oscier D.G."/>
<person name="Mould S.J."/>
<person name="Doehner H."/>
<person name="Doehner K."/>
<person name="Rommens J.M."/>
<person name="Vincent J.B."/>
<person name="Venter J.C."/>
<person name="Li P.W."/>
<person name="Mural R.J."/>
<person name="Adams M.D."/>
<person name="Tsui L.-C."/>
</authorList>
<dbReference type="PubMed" id="12690205"/>
<dbReference type="DOI" id="10.1126/science.1083423"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANTS GLU-701 AND ILE-851</scope>
<source>
<tissue>Brain</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="PLoS Genet." volume="4" first="E21" last="E21">
<title>Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein.</title>
<authorList>
<person name="Kerns J.A."/>
<person name="Emerman M."/>
<person name="Malik H.S."/>
</authorList>
<dbReference type="PubMed" id="18225958"/>
<dbReference type="DOI" id="10.1371/journal.pgen.0040021"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271; THR-273; SER-275; SER-284; SER-302; SER-378; SER-387 AND THR-393</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="RNA Biol." volume="5" first="65" last="67">
<title>ZAP-mediated mRNA degradation.</title>
<authorList>
<person name="Zhu Y."/>
<person name="Gao G."/>
</authorList>
<dbReference type="PubMed" id="18418085"/>
<dbReference type="DOI" id="10.4161/rna.5.2.6044"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-257; SER-284; SER-335; SER-387 AND THR-393</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="396" first="696" last="702">
<title>Expression and RNA-binding of human zinc-finger antiviral protein.</title>
<authorList>
<person name="Jeong M.S."/>
<person name="Kim E.J."/>
<person name="Jang S.B."/>
</authorList>
<dbReference type="PubMed" id="20451500"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.04.164"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>RNA-BINDING</scope>
<scope>DOMAIN N-TERMINAL</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="J. Virol." volume="84" first="4504" last="4512">
<title>Identification of a dominant negative inhibitor of human zinc finger antiviral protein reveals a functional endogenous pool and critical homotypic interactions.</title>
<authorList>
<person name="Law L.M."/>
<person name="Albin O.R."/>
<person name="Carroll J.W."/>
<person name="Jones C.T."/>
<person name="Rice C.M."/>
<person name="Macdonald M.R."/>
</authorList>
<dbReference type="PubMed" id="20181706"/>
<dbReference type="DOI" id="10.1128/JVI.02018-09"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Protein Cell" volume="1" first="956" last="964">
<title>DEXH-Box protein DHX30 is required for optimal function of the zinc-finger antiviral protein.</title>
<authorList>
<person name="Ye P."/>
<person name="Liu S."/>
<person name="Zhu Y."/>
<person name="Chen G."/>
<person name="Gao G."/>
</authorList>
<dbReference type="PubMed" id="21204022"/>
<dbReference type="DOI" id="10.1007/s13238-010-0117-8"/>
</citation>
<scope>INTERACTION WITH DHX30</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284; SER-302; SER-335; SER-378; THR-393 AND SER-492</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-572 (ISOFORM 3)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Trends Biochem. Sci." volume="35" first="208" last="219">
<title>Toward a unified nomenclature for mammalian ADP-ribosyltransferases.</title>
<authorList>
<person name="Hottiger M.O."/>
<person name="Hassa P.O."/>
<person name="Luscher B."/>
<person name="Schuler H."/>
<person name="Koch-Nolte F."/>
</authorList>
<dbReference type="PubMed" id="20106667"/>
<dbReference type="DOI" id="10.1016/j.tibs.2009.12.003"/>
</citation>
<scope>NOMENCLATURE</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Nat. Immunol." volume="12" first="11" last="12">
<title>ZAPS electrifies RIG-I signaling.</title>
<authorList>
<person name="Liu H.M."/>
<person name="Gale M. Jr."/>
</authorList>
<dbReference type="PubMed" id="21169998"/>
<dbReference type="DOI" id="10.1038/ni0111-11"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Nat. Immunol." volume="12" first="37" last="44">
<title>ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses.</title>
<authorList>
<person name="Hayakawa S."/>
<person name="Shiratori S."/>
<person name="Yamato H."/>
<person name="Kameyama T."/>
<person name="Kitatsuji C."/>
<person name="Kashigi F."/>
<person name="Goto S."/>
<person name="Kameoka S."/>
<person name="Fujikura D."/>
<person name="Yamada T."/>
<person name="Mizutani T."/>
<person name="Kazumata M."/>
<person name="Sato M."/>
<person name="Tanaka J."/>
<person name="Asaka M."/>
<person name="Ohba Y."/>
<person name="Miyazaki T."/>
<person name="Imamura M."/>
<person name="Takaoka A."/>
</authorList>
<dbReference type="PubMed" id="21102435"/>
<dbReference type="DOI" id="10.1038/ni.1963"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
<scope>INTERACTION WITH DDX58/RIG-I</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="15834" last="15839">
<title>Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation.</title>
<authorList>
<person name="Zhu Y."/>
<person name="Chen G."/>
<person name="Lv F."/>
<person name="Wang X."/>
<person name="Ji X."/>
<person name="Xu Y."/>
<person name="Sun J."/>
<person name="Wu L."/>
<person name="Zheng Y.T."/>
<person name="Gao G."/>
</authorList>
<dbReference type="PubMed" id="21876179"/>
<dbReference type="DOI" id="10.1073/pnas.1101676108"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EXOSC3; EXOSC7; PARN; DCP2; DCP1A AND XRN1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.M111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E39159" last="E39159">
<title>Zinc-finger antiviral protein inhibits XMRV infection.</title>
<authorList>
<person name="Wang X."/>
<person name="Tu F."/>
<person name="Zhu Y."/>
<person name="Gao G."/>
</authorList>
<dbReference type="PubMed" id="22720057"/>
<dbReference type="DOI" id="10.1371/journal.pone.0039159"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-257; THR-273; SER-275; SER-284; SER-302; SER-335; SER-355; SER-378; THR-393; SER-407; SER-469; SER-492; SER-494; THR-554 AND SER-590</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275; SER-284 AND SER-492</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="7336" last="7344">
<title>Structural basis for lack of ADP-ribosyltransferase activity in poly(ADP-ribose) polymerase-13/zinc finger antiviral protein.</title>
<authorList>
<person name="Karlberg T."/>
<person name="Klepsch M."/>
<person name="Thorsell A.G."/>
<person name="Andersson C.D."/>
<person name="Linusson A."/>
<person name="Schuler H."/>
</authorList>
<dbReference type="PubMed" id="25635049"/>
<dbReference type="DOI" id="10.1074/jbc.M114.630160"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.05 ANGSTROMS) OF 724-896</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF HIS-810 AND ASN-830</scope>
</reference>
<comment type="function">
<text evidence="22 25 27 28">Antiviral protein which inhibits the replication of viruses by recruiting the cellular RNA degradation machineries to degrade the viral mRNAs. Binds to a ZAP-responsive element (ZRE) present in the target viral mRNA, recruits cellular poly(A)-specific ribonuclease PARN to remove the poly(A) tail, and the 3'-5' exoribonuclease complex exosome to degrade the RNA body from the 3'-end. It also recruits the decapping complex DCP1-DCP2 through RNA helicase p72 (DDX17) to remove the cap structure of the viral mRNA to initiate its degradation from the 5'-end. Its target viruses belong to families which include retroviridae: human immunodeficiency virus type 1 (HIV-1), moloney and murine leukemia virus (MoMLV) and xenotropic MuLV-related virus (XMRV), filoviridae: ebola virus (EBOV) and marburg virus (MARV), togaviridae: sindbis virus (SINV) and Ross river virus (RRV). Specifically targets the multiply spliced but not unspliced or singly spliced HIV-1 mRNAs for degradation. Isoform 1 is a more potent viral inhibitor than isoform 2. Isoform 2 acts as a positive regulator of DDX58/RIG-I signaling resulting in activation of the downstream effector IRF3 leading to the expression of type I IFNs and IFN stimulated genes (ISGs).</text>
</comment>
<comment type="biophysicochemical properties">
<temperatureDependence>
<text evidence="24">Thermostable.</text>
</temperatureDependence>
</comment>
<comment type="subunit">
<text evidence="13 23 25 26 27">Homodimer or homooligomer. Homooligomerization is essential for its antiviral activity. Interacts with EXOSC5 (By similarity). Interacts (via N-terminal domain) with DDX17 in an RNA-independent manner (By similarity). Interacts with EXOSC3, EXOSC7, DCP2 and DCP1A. Interacts with PARN in an RNA-independent manner. Interacts with XRN1 in an RNA-dependent manner. Isoform 2 interacts (via zinc-fingers) with DDX58/RIG-I in an RNA-dependent manner. Interacts (via N-terminal domain) with DHX30 (via N-terminus) in an RNA-independent manner.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-922559"/>
<interactant intactId="EBI-995350">
<id>O95786</id>
<label>DDX58</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text evidence="13">Localizes in the cytoplasm at steady state, but shuttles between nucleus and cytoplasm in a XPO1-dependent manner.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q7Z2W4-1</id>
<name>1</name>
<name>ZAPL</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q7Z2W4-2</id>
<name>2</name>
<name>ZAPS</name>
<sequence type="described" ref="VSP_010269"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>Q7Z2W4-3</id>
<name>3</name>
<sequence type="described" ref="VSP_010270 VSP_010271"/>
<text evidence="8">No experimental confirmation available. Contains a phosphoserine at position 572.</text>
</isoform>
<isoform>
<id>Q7Z2W4-4</id>
<name>4</name>
<sequence type="described" ref="VSP_010268"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>Q7Z2W4-5</id>
<name>5</name>
<sequence type="described" ref="VSP_010268 VSP_010269"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="induction">
<text evidence="25">By type I interferon (IFN) and viruses. Isoform 2 is up-regulated by 3'-PPP-RNA.</text>
</comment>
<comment type="domain">
<text evidence="24 29">The N-terminal domain is sufficient to bind to viral RNAs and promote their degradation. The second and fourth zinc fingers are involved in binding to specific viral RNAs (PubMed:20451500). Contains a divergent PARP homology ADP-ribosyltransferase domain which lacks the structural requirements for NAD[+] binding. It is therefore inactive (PubMed:25635049).</text>
</comment>
<comment type="PTM">
<text evidence="13">Phosphorylation at Ser-275 is essential for sequential phosphorylation of Ser-271, Ser-267, Ser-263 and Ser-257 by GSK3-beta. Phosphorylation by GSK3-beta enhances its antiviral activity (By similarity).</text>
</comment>
<dbReference type="EMBL" id="AF138863">
<property type="protein sequence ID" value="AAF61195.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK055851">
<property type="protein sequence ID" value="BAB71028.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK023350">
<property type="protein sequence ID" value="BAB14537.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX571742">
<property type="protein sequence ID" value="CAE11868.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH236950">
<property type="protein sequence ID" value="EAL24040.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH236950">
<property type="protein sequence ID" value="EAL24041.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC025308">
<property type="protein sequence ID" value="AAH25308.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC027462">
<property type="protein sequence ID" value="AAH27462.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC033105">
<property type="protein sequence ID" value="AAH33105.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC040956">
<property type="protein sequence ID" value="AAH40956.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55171.1">
<molecule id="Q7Z2W4-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5851.1">
<molecule id="Q7Z2W4-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_064504.2">
<molecule id="Q7Z2W4-1"/>
<property type="nucleotide sequence ID" value="NM_020119.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_078901.3">
<molecule id="Q7Z2W4-2"/>
<property type="nucleotide sequence ID" value="NM_024625.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.133512"/>
<dbReference type="PDB" id="2X5Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.05"/>
<property type="chains" value="A=724-896"/>
</dbReference>
<dbReference type="PDB" id="4X52">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.08"/>
<property type="chains" value="A/B/C/D=726-896"/>
</dbReference>
<dbReference type="PDBsum" id="2X5Y"/>
<dbReference type="PDBsum" id="4X52"/>
<dbReference type="ProteinModelPortal" id="Q7Z2W4"/>
<dbReference type="SMR" id="Q7Z2W4"/>
<dbReference type="BioGrid" id="121203">
<property type="interactions" value="156"/>
</dbReference>
<dbReference type="DIP" id="DIP-37896N"/>
<dbReference type="IntAct" id="Q7Z2W4">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="MINT" id="MINT-5006396"/>
<dbReference type="STRING" id="9606.ENSP00000242351"/>
<dbReference type="iPTMnet" id="Q7Z2W4"/>
<dbReference type="PhosphoSitePlus" id="Q7Z2W4"/>
<dbReference type="SwissPalm" id="Q7Z2W4"/>
<dbReference type="BioMuta" id="ZC3HAV1"/>
<dbReference type="DMDM" id="223634727"/>
<dbReference type="EPD" id="Q7Z2W4"/>
<dbReference type="MaxQB" id="Q7Z2W4"/>
<dbReference type="PaxDb" id="Q7Z2W4"/>
<dbReference type="PeptideAtlas" id="Q7Z2W4"/>
<dbReference type="PRIDE" id="Q7Z2W4"/>
<dbReference type="Ensembl" id="ENST00000242351">
<molecule id="Q7Z2W4-1"/>
<property type="protein sequence ID" value="ENSP00000242351"/>
<property type="gene ID" value="ENSG00000105939"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000471652">
<molecule id="Q7Z2W4-2"/>
<property type="protein sequence ID" value="ENSP00000419855"/>
<property type="gene ID" value="ENSG00000105939"/>
</dbReference>
<dbReference type="GeneID" id="56829"/>
<dbReference type="KEGG" id="hsa:56829"/>
<dbReference type="UCSC" id="uc003vun.4">
<molecule id="Q7Z2W4-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="56829"/>
<dbReference type="DisGeNET" id="56829"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000105939.12"/>
<dbReference type="GeneCards" id="ZC3HAV1"/>
<dbReference type="H-InvDB" id="HIX0007129"/>
<dbReference type="HGNC" id="HGNC:23721">
<property type="gene designation" value="ZC3HAV1"/>
</dbReference>
<dbReference type="HPA" id="HPA047818"/>
<dbReference type="HPA" id="HPA059096"/>
<dbReference type="MIM" id="607312">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q7Z2W4"/>
<dbReference type="OpenTargets" id="ENSG00000105939"/>
<dbReference type="PharmGKB" id="PA134944289"/>
<dbReference type="eggNOG" id="ENOG410IEI4">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZFB8">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119084"/>
<dbReference type="HOVERGEN" id="HBG050384"/>
<dbReference type="InParanoid" id="Q7Z2W4"/>
<dbReference type="KO" id="K15259"/>
<dbReference type="PhylomeDB" id="Q7Z2W4"/>
<dbReference type="TreeFam" id="TF338389"/>
<dbReference type="Reactome" id="R-HSA-6802952">
<property type="pathway name" value="Signaling by BRAF and RAF fusions"/>
</dbReference>
<dbReference type="ChiTaRS" id="ZC3HAV1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q7Z2W4"/>
<dbReference type="GeneWiki" id="ZC3HAV1"/>
<dbReference type="GenomeRNAi" id="56829"/>
<dbReference type="PMAP-CutDB" id="Q7Z2W4"/>
<dbReference type="PRO" id="PR:Q7Z2W4"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000105939"/>
<dbReference type="CleanEx" id="HS_ZC3HAV1"/>
<dbReference type="ExpressionAtlas" id="Q7Z2W4">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q7Z2W4">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045071">
<property type="term" value="P:negative regulation of viral genome replication"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032727">
<property type="term" value="P:positive regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061014">
<property type="term" value="P:positive regulation of mRNA catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900246">
<property type="term" value="P:positive regulation of RIG-I signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.1000.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR012317">
<property type="entry name" value="Poly(ADP-ribose)pol_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR004170">
<property type="entry name" value="WWE-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR037197">
<property type="entry name" value="WWE_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000571">
<property type="entry name" value="Znf_CCCH"/>
</dbReference>
<dbReference type="InterPro" id="IPR036855">
<property type="entry name" value="Znf_CCCH_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00644">
<property type="entry name" value="PARP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02825">
<property type="entry name" value="WWE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF117839">
<property type="entry name" value="SSF117839"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51059">
<property type="entry name" value="PARP_CATALYTIC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50918">
<property type="entry name" value="WWE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50103">
<property type="entry name" value="ZF_C3H1"/>
<property type="match status" value="3"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="6 10">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Zinc finger CCCH-type antiviral protein 1" id="PRO_0000211343">
<location>
<begin position="2"/>
<end position="902"/>
</location>
</feature>
<feature type="domain" description="WWE" evidence="16">
<location>
<begin position="594"/>
<end position="681"/>
</location>
</feature>
<feature type="domain" description="PARP catalytic" evidence="17">
<location>
<begin position="716"/>
<end position="902"/>
</location>
</feature>
<feature type="zinc finger region" description="C3H1-type 1" evidence="18">
<location>
<begin position="73"/>
<end position="86"/>
</location>
</feature>
<feature type="zinc finger region" description="C3H1-type 2" evidence="18">
<location>
<begin position="88"/>
<end position="110"/>
</location>
</feature>
<feature type="zinc finger region" description="C3H1-type 3" evidence="18">
<location>
<begin position="150"/>
<end position="172"/>
</location>
</feature>
<feature type="zinc finger region" description="C3H1-type 4" evidence="18">
<location>
<begin position="169"/>
<end position="193"/>
</location>
</feature>
<feature type="region of interest" description="N-terminal domain">
<location>
<begin position="2"/>
<end position="254"/>
</location>
</feature>
<feature type="region of interest" description="Binding to EXOSC5" evidence="13">
<location>
<begin position="224"/>
<end position="254"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="13">
<location>
<begin position="69"/>
<end position="76"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal" evidence="13">
<location>
<begin position="285"/>
<end position="292"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="6 10">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta" evidence="7 11">
<location>
<position position="257"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta" evidence="15">
<location>
<position position="263"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta" evidence="15">
<location>
<position position="267"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta" evidence="5">
<location>
<position position="271"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 11">
<location>
<position position="273"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 11 12">
<location>
<position position="275"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 4 5 7 8 9 11 12">
<location>
<position position="284"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 8 11">
<location>
<position position="302"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="327"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8 11">
<location>
<position position="335"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="355"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 8 11">
<location>
<position position="378"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 7">
<location>
<position position="387"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 7 8 11">
<location>
<position position="393"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="407"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="469"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 11 12">
<location>
<position position="492"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="494"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="554"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="590"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4 and isoform 5." id="VSP_010268" evidence="31 33">
<location>
<begin position="1"/>
<end position="539"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_010270" evidence="31">
<original>DSLSDVTSTTSSRVDDHDSEEICLDHLCKGCPLNGSCSKVHFHLPYRWQMLIGKTWTDFEHMETIEKGYCNPGIHLCSVGSYTINFRVMSCDSFPIRRLSTPSSVTKPANSVFTTKWIWYWKNESGTWIQYGEE</original>
<variation>GKYKGKTLWASTFVHDIPNGSSQVVDKTTDVEKTGATGFGLTMAVKAEKDMLCTGSQSLRNLVPTTPGESTAPAQVSTLPQSPAALSSSNRAAVWGAQGQNCTQVPVSSASELTRKTTGSAQCKSLKDKGASVS</variation>
<location>
<begin position="491"/>
<end position="624"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_010271" evidence="31">
<location>
<begin position="625"/>
<end position="902"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 5." id="VSP_010269" evidence="32 33">
<original>DHQPAKTSSVSLTATFRPQEDFCFLSSKKYKLSEIHHLHPEYVRVSEHFKASMKNFKIEKIKKIENSELLDKFTWKKSQMKEEGKLLFYATSRAYVESICSNNFDSFLHETHENKYGKGIYFAKDAIYSHKNCPYDAKNVVMFVAQVLVGKFTEGNITYTSPPPQFDSCVDTRSNPSVFVIFQKDQVYPQYVIEYTEDKACVIS</original>
<variation>E</variation>
<location>
<begin position="699"/>
<end position="902"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2236426." id="VAR_018454" evidence="19">
<original>R</original>
<variation>K</variation>
<location>
<position position="485"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2297241." id="VAR_018455" evidence="19 30">
<original>H</original>
<variation>Q</variation>
<location>
<position position="565"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2297236." id="VAR_054319" evidence="19 20 21">
<original>Q</original>
<variation>E</variation>
<location>
<position position="701"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3735007." id="VAR_018456" evidence="20 21">
<original>T</original>
<variation>I</variation>
<location>
<position position="851"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the structural inability to bind NAD(+); when associated with Y-830." evidence="29">
<original>H</original>
<variation>N</variation>
<location>
<position position="810"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the structural inability to bind NAD(+); when associated with N-810." evidence="29">
<original>N</original>
<variation>Y</variation>
<location>
<position position="830"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAE11868." ref="3" evidence="34">
<original>A</original>
<variation>T</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="729"/>
<end position="732"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="738"/>
<end position="748"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="754"/>
<end position="763"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="765"/>
<end position="778"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="783"/>
<end position="790"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="791"/>
<end position="793"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="794"/>
<end position="800"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="804"/>
<end position="807"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="812"/>
<end position="814"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="816"/>
<end position="823"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="824"/>
<end position="830"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="835"/>
<end position="837"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="838"/>
<end position="845"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="849"/>
<end position="852"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="866"/>
<end position="869"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="871"/>
<end position="873"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="876"/>
<end position="879"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="882"/>
<end position="884"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="885"/>
<end position="895"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2X5Y"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250"/>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q3UPF5"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8K3Y6"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00248"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00397"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00723"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18225958"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20181706"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20451500"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21102435"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21204022"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21876179"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22720057"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25635049"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source ref="1"/>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source ref="1"/>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<sequence length="902" mass="101431" checksum="72AB311D23658E24" modified="2009-02-10" version="3">
MADPEVCCFITKILCAHGGRMALDALLQEIALSEPQLCEVLQVAGPDRFVVLETGGEAGI
TRSVVATTRARVCRRKYCQRPCDNLHLCKLNLLGRCNYSQSERNLCKYSHEVLSEENFKV
LKNHELSGLNKEELAVLLLQSDPFFMPEICKSYKGEGRQQICNQQPPCSRLHICDHFTRG
NCRFPNCLRSHNLMDRKVLAIMREHGLNPDVVQNIQDICNSKHMQKNPPGPRAPSSHRRN
MAYRARSKSRDRFFQGSQEFLASASASAERSCTPSPDQISHRASLEDAPVDDLTRKFTYL
GSQDRARPPSGSSKATDLGGTSQAGTSQRFLENGSQEDLLHGNPGSTYLASNSTSAPNWK
SLTSWTNDQGARRKTVFSPTLPAARSSLGSLQTPEAVTTRKGTGLLSSDYRIINGKSGTQ
DIQPGPLFNNNADGVATDITSTRSLNYKSTSSGHREISSPRIQDAGPASRDVQATGRIAD
DADPRVALVNDSLSDVTSTTSSRVDDHDSEEICLDHLCKGCPLNGSCSKVHFHLPYRWQM
LIGKTWTDFEHMETIEKGYCNPGIHLCSVGSYTINFRVMSCDSFPIRRLSTPSSVTKPAN
SVFTTKWIWYWKNESGTWIQYGEEKDKRKNSNVDSSYLESLYQSCPRGVVPFQAGSRNYE
LSFQGMIQTNIASKTQKDVIRRPTFVPQWYVQQMKRGPDHQPAKTSSVSLTATFRPQEDF
CFLSSKKYKLSEIHHLHPEYVRVSEHFKASMKNFKIEKIKKIENSELLDKFTWKKSQMKE
EGKLLFYATSRAYVESICSNNFDSFLHETHENKYGKGIYFAKDAIYSHKNCPYDAKNVVM
FVAQVLVGKFTEGNITYTSPPPQFDSCVDTRSNPSVFVIFQKDQVYPQYVIEYTEDKACV
IS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>